
"NIH Ceases COVID Treatment Guidelines"
The National Institutes of Health (NIH) has ended its influential COVID-19 Treatment Guidelines, marking a milestone in the pandemic. The availability of COVID-19 treatments has evolved over the past four years, with Pfizer's Paxlovid and Merck's molnupiravir being authorized as outpatient treatments. However, low usage rates and challenges in prescribing these drugs persist, contributing to underuse of effective treatments. Moving forward, specialty doctors groups will take over the responsibility of providing COVID-19 treatment guidance, as the evolution of treatments offers valuable lessons for dealing with new emerging infectious diseases.


